Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

Semax research

6 articles to explore, with links to 8 original sources.

About Semax

Semax is a seven-residue peptide analogue associated with an ACTH-derived sequence.

Explore study findings

  • What the 2026 FDA Appraisal Found About Semax and Stroke

    Semax is a synthetic seven-amino-acid peptide derived in part from a region of adrenocorticotropic hormone. It has been studied in relation to cerebral ischemia, a loss of adequate blood flow to brain tissue.

    2 sources (2018, 2026)

  • What the Interim Compounding Policy Actually Covers for Semax

    Semax is a synthetic seven-amino-acid peptide. In 2026, FDA and HHS documents discussed specific Semax-related bulk substances. These sources explain a regulatory context, not a finding that Semax improves memory or recovery.

    3 sources (2026)

Check methods and identity

  • What Semax Changed in Gene Measurements After Experimental Ischemia

    Semax is a synthetic peptide based in part on a region of adrenocorticotropic hormone. Researchers have used it in animal studies to ask whether parts of the brain respond differently after temporary loss and restoration of blood flow.

    1 source (2024)

  • How to Read a Semax Brain Imaging Result in Healthy Volunteers

    Semax is a synthetic seven-amino-acid peptide. An older imaging study compared Semax, Selank and placebo in healthy volunteers. This direct study measured brain connectivity over a short interval rather than showing whether cognition or daily function improved.

    1 source (2020)

Interpret the evidence

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.